Amedeo Smart

Free Medical Literature Service

 

Amedeo

Autoimmune Disorders
  Free Subscription

Articles published in
J Rheumatol
    June 2026
  1. LECLAIR V, Berger C, Bouchard-Marmen M, Bourre-Tessier J, et al
    Does the ACR/EULAR Total Improvement Score reflect how individuals with autoimmune inflammatory myopathies feel and function?
    J Rheumatol. 2026 Jun 15:jrheum.2026-0046. doi: 10.3899/jrheum.2026-0046.
    >> Share

  2. GARCIA-ESCUDERO P, Iturricha Ochoa de Echaguen A, Beltran de Otalora Garcia S, Lopez I Gomez M, et al
    Uncharted Territory: Adult-Onset Autoinflammatory Syndrome With a Newly Identified Mutation in the Coatomer WD-Associated Region of COPA Gene.
    J Rheumatol. 2026 Jun 15:jrheum.2025-1267. doi: 10.3899/jrheum.2025-1267.
    >> Share

  3. JAMES EA
    From Mouth to Joint: Citrullinated Bacteria in Driving Synovial Autoimmunity.
    J Rheumatol. 2026 Jun 1:jrheum.2026-0410. doi: 10.3899/jrheum.2026-0410.
    >> Share

  4. ELOSEILY E, Romankevych I, Sabit T, Berklite L, et al
    Hepatic Manifestations in Systemic Juvenile Idiopathic Arthritis and Macrophage Activation Syndrome.
    J Rheumatol. 2026;53:669-678.
    >> Share

    May 2026
  5. CLIFFORD AH, Thai J, Yip A, Homik J, et al
    How Often Does Follow up 18F-FDG PET Improve in Treated Patients with Giant Cell Arteritis: a Systematic Review and Meta-Analysis.
    J Rheumatol. 2026 May 15:jrheum.2026-0050. doi: 10.3899/jrheum.2026-0050.
    >> Share

  6. RANDELL RL, Ardalan K, Carson NB, Li Z, et al
    Sex Differences in PROMIS Pediatric Depressive Symptoms, Anxiety, and Psychological Stress Among Children and Adolescents Living With Pediatric Rheumatic Diseases.
    J Rheumatol. 2026;53:547-555.
    >> Share

  7. MISZTAL MC, Mukherjee T, Couse M, Dissanayake D, et al
    Novel DNASE2 Variants Linked With Neonatal Acute Liver Failure and Monogenic Systemic Lupus Erythematosus.
    J Rheumatol. 2026 May 1:jrheum.2025-1111. doi: 10.3899/jrheum.2025-1111.
    >> Share

    April 2026
  8. REBOLLO-GIMENEZ AI, Baird T, Feldman BM, Hinze C, et al
    Systematic literature review informing PReS/CARRA-endorsed recommendations for the treat-to-target strategy in juvenile dermatomyositis.
    J Rheumatol. 2026 Apr 15:jrheum.2025-1157. doi: 10.3899/jrheum.2025-1157.
    >> Share

  9. LEVIN D, Choi M, Kawasoe J, Durand C, et al
    Autoantibodies and Relapse of Systemic Sclerosis After Autologous Hematopoietic Cell Transplantation.
    J Rheumatol. 2026 Apr 15:jrheum.2025-0987. doi: 10.3899/jrheum.2025-0987.
    >> Share

  10. HARRIS JG, Singleton JH, Ting TV, Oberle EJ, et al
    Evaluation of Health Disparities in Outcomes of Patients With Juvenile Idiopathic Arthritis.
    J Rheumatol. 2026;53:435-442.
    >> Share

  11. SONG J, Jiang H, Wang X, Gong K, et al
    Evolution of the Diagnostic Paradigm for Giant Cell Arteritis: From Histopathology to Multi-Modal Imaging Integration Running title: GCA: Histology to Imaging.
    J Rheumatol. 2026 Apr 1:jrheum.2025-1205. doi: 10.3899/jrheum.2025-1205.
    >> Share

  12. MCMAHON M, Skaggs BJ
    Rethinking Cardiovascular Screening in Systemic Lupus Erythematosus.
    J Rheumatol. 2026 Apr 1:jrheum.2026-0136. doi: 10.3899/jrheum.2026-0136.
    >> Share

  13. MILLER-BARMAK A, Mandel-Shorer N, Tobias L, Butbul Aviel Y, et al
    Antiphospholipid Syndrome in Identical Pediatric Twins.
    J Rheumatol. 2026 Apr 1:jrheum.2025-0472. doi: 10.3899/jrheum.2025-0472.
    >> Share

    March 2026
  14. CONCANNON HR, Sun K, Rogers JL, Clowse MEB, et al
    Differences in Self-Reported Medication Nonadherence and its Drivers in Young Adults versus Older Adults with Systemic Lupus Erythematosus.
    J Rheumatol. 2026 Mar 1:jrheum.2025-0602. doi: 10.3899/jrheum.2025-0602.
    >> Share

    February 2026
  15. MANZI S
    Trends in Acute Coronary Syndromes in Systemic Lupus Erythematosus: Are We Moving in the Right Direction?
    J Rheumatol. 2026 Feb 15:jrheum.2026-0067. doi: 10.3899/jrheum.2026-0067.
    >> Share

  16. RONDLA M, Zaazouee MS, Perumangote Vasudevan AA, Mathialagan K, et al
    Gut Microbiota as a Biomarker and Target in Biologic Therapy for Autoimmune and Immune-Mediated Arthritis- a Systematic Review.
    J Rheumatol. 2026 Feb 15:jrheum.2025-0915. doi: 10.3899/jrheum.2025-0915.
    >> Share

  17. SINGH A, Gamboa-Cardenas RV, Pimentel-Quiroz VR, Rodriguez-Bellido Z, et al
    Association of Daily Glucocorticoid Dose With Worse Patient-Reported Outcomes in Systemic Lupus Erythematosus: Data From the Almenara Lupus Cohort.
    J Rheumatol. 2026 Feb 15:jrheum.2025-0394. doi: 10.3899/jrheum.2025-0394.
    >> Share

  18. TSAI Z, Huber AM, Oen K, Proulx-Gauthier JP, et al
    Effect of Treatment Changes on Health-Related Quality of Life in Canadian Children With Juvenile Idiopathic Arthritis: Results From ReACCh-Out and CAPRI.
    J Rheumatol. 2026;53:186-193.
    >> Share

  19. KIM K, Claybaugh D, Patino-Martinez E, Temesgen-Oyelakin Y, et al
    Genome-Wide Association Study Identifies Genetic Loci for Antibody Response to SARS-CoV-2 Vaccines in Patients With Systemic Autoimmune Diseases and Healthy Individuals.
    J Rheumatol. 2026 Feb 1:jrheum.2025-0770. doi: 10.3899/jrheum.2025-0770.
    >> Share

  20. FORNARO M, Lacedonia D, Cavagna L, Airo P, et al
    Prognostic and Functional Trajectories in Idiopathic Pulmonary Fibrosis and Systemic Autoimmune Rheumatic Disease-Associated Interstitial Lung Disease: Insights From an Italian Multicenter Cohort.
    J Rheumatol. 2026 Feb 1:jrheum.2025-0610. doi: 10.3899/jrheum.2025-0610.
    >> Share

    January 2026
  21. PLANTINGA LC, Fitzpatrick J, Dey M, Dall'Era M, et al
    Perceived and Objective Physical Function in Two U.S., Population-Based Cohorts of Adults with Systemic Lupus Erythematosus.
    J Rheumatol. 2026 Jan 15:jrheum.2025-0857. doi: 10.3899/jrheum.2025-0857.
    >> Share

  22. TAUBMANN J, Hagen M, Muller F, Wirsching A, et al
    Effects of CD19 CAR T Cell Therapy on Quality of Life and Direct Healthcare Costs in Systemic Lupus Erythematosus: A Preliminary Analysis.
    J Rheumatol. 2026;53:33-37.
    >> Share

  23. WEISS PF, Ruperto N, Quebe-Fehling E, Shew A, et al
    Juvenile Spondyloarthritis Disease Activity Index Validation in Enthesitis-Related Arthritis and Juvenile Psoriatic Arthritis in a Prospective Clinical Trial Setting.
    J Rheumatol. 2026;53:85-94.
    >> Share

    December 2025
  24. QIAO J, Ma Y, Zhang X, Zhu G, et al
    Evaluating the Applicability of the EULAR/ACR-2019, SLICC-2012, and ACR-1997 Classification Criteria for Systemic Lupus Erythematosus in Children: a multicenter study.
    J Rheumatol. 2025 Dec 15:jrheum.2025-0559. doi: 10.3899/jrheum.2025-0559.
    >> Share

  25. BENSON KRK, Becerril A, Park J, Plantinga L, et al
    The Impact of Everyday Discrimination on Systemic Lupus Erythematous Disease Activity and Mental Health Outcomes.
    J Rheumatol. 2025 Dec 15:jrheum.2025-0631. doi: 10.3899/jrheum.2025-0631.
    >> Share

  26. ALY S, Parastandehchehr G, Bernatsky S, Vinet E, et al
    A Global Survey of Quinacrine Use in Systemic and Cutaneous Lupus Erythematosus.
    J Rheumatol. 2025 Dec 1:jrheum.2025-0757. doi: 10.3899/jrheum.2025-0757.
    >> Share

  27. DAVIS NA, Wang J, Wang X, Getachew LS, et al
    Investigating factors associated with respiratory syncytial virus vaccination and breakthrough infection among patients with systemic autoimmune rheumatic diseases.
    J Rheumatol. 2025 Dec 1:jrheum.2025-0934. doi: 10.3899/jrheum.2025-0934.
    >> Share

    November 2025
  28. O'CONNOR SK, Devarajan P, Liu J, Maldonado MA, et al
    The Renal Activity Index for Lupus: Validation for Prediction of Kidney Inflammation in Adult Patients with Lupus Nephritis.
    J Rheumatol. 2025 Nov 15:jrheum.2025-0504. doi: 10.3899/jrheum.2025-0504.
    >> Share

  29. PATEL H, Stoots S, Von Feldt J, Baker JF, et al
    Performance of Risk Score Calculators in the Identification of Coronary Artery Calcification in Patients with Systemic Lupus Erythematosus.
    J Rheumatol. 2025 Nov 15:jrheum.2025-0465. doi: 10.3899/jrheum.2025-0465.
    >> Share

  30. PARPERIS K, Bertsias G, Lampi M, Constantinou M, et al
    Time trends in acute coronary syndrome hospitalizations and outcomes in patients with Systemic Lupus Erythematosus: A US inpatient cohort analysis.
    J Rheumatol. 2025 Nov 15:jrheum.2025-0627. doi: 10.3899/jrheum.2025-0627.
    >> Share

  31. QI W, Yuen SY, Popescu ML, Yang R, et al
    The Burden of Enthesitis, Inflammatory Arthritis and Tenosynovitis on Musculoskeletal Ultrasound in Systemic Lupus Erythematous: A Scoping Review.
    J Rheumatol. 2025 Nov 15:jrheum.2025-0684. doi: 10.3899/jrheum.2025-0684.
    >> Share

  32. MAYO-JUANATEY A, Castaneda S, Calvo-Rio V, Garijo-Bufort M, et al
    Anifrolumab in Systemic Lupus Erythematosus With Severe Hematological Manifestations: A Spanish Multicenter Study.
    J Rheumatol. 2025 Nov 5:jrheum.2025-0658.C1. doi: 10.3899/jrheum.2025-0658.
    >> Share

  33. CHAN YN, Ardalan K, Lin L, Chen D, et al
    Congruence Between Child Self-Reported and Caregiver-Proxy Health-Related Quality of Life in Children with Juvenile Idiopathic Arthritis and Systemic Lupus Erythematosus.
    J Rheumatol. 2025 Nov 1:jrheum.2025-0598. doi: 10.3899/jrheum.2025-0598.
    >> Share

  34. CARLI L, Cavagna L, Cardelli C, Fattorini F, et al
    Anifrolumab therapy in Dermatomyositis: new insights from refractory patients.
    J Rheumatol. 2025 Nov 1:jrheum.2025-0773. doi: 10.3899/jrheum.2025-0773.
    >> Share

  35. BARONAITE HANSEN R, Faurschou M, Jacobsen S
    Comorbidity Development and Mortality During 10 Years of Follow-up in Danish Nationwide Cohort of 3,178 Patients with Systemic Lupus Erythematosus.
    J Rheumatol. 2025 Nov 1:jrheum.2025-0015. doi: 10.3899/jrheum.2025-0015.
    >> Share

  36. KILBAS G, Ayduran S, Sener S, Coskuner T, et al
    Results of a Nationwide Multicenter Study in Childhood Sjogren Disease.
    J Rheumatol. 2025;52:1141-1150.
    >> Share

  37. FLATMAN LK, Bernatsky S, Berard A, Vinet E, et al
    Patterns of Use and Discontinuation for Tumor Necrosis Factor Inhibitors in Pregnant Women: Insights From a Real-World Sample.
    J Rheumatol. 2025;52:1159-1165.
    >> Share

    October 2025
  38. OGBONNAYA SA, Williams S, Lightbourne M, Brown RJ, et al
    Type B Insulin Resistance: A Case Report of a Rare Complication of Systemic Lupus Erythematosus.
    J Rheumatol. 2025 Oct 15:jrheum.2025-0533. doi: 10.3899/jrheum.2025-0533.
    >> Share

  39. SRINIVASALU H, Beukelman T, Dennos A, Chen A, et al
    Juvenile Psoriatic Arthritis Inception Cohort in the Childhood Arthritis and Rheumatology Research Alliance (CARRA) Registry: Characteristics and Early Disease Outcomes.
    J Rheumatol. 2025;52:1013-1020.
    >> Share

  40. PONGTARAKULPANIT N, Bishnoi A, Chandra T, Dzanko S, et al
    Quantifying Cutaneous Dermatomyositis: A Novel 3D Image-based Approach.
    J Rheumatol. 2025 Oct 1:jrheum.2025-0537. doi: 10.3899/jrheum.2025-0537.
    >> Share

  41. LOPEZ-MARTINEZ J, Esplugues Clos J, Fernandez-Valmana A, Feijoo-Masso C, et al
    Renal AA Amyloidosis Associated With Systemic Lupus Erythematosus Treated With Anakinra.
    J Rheumatol. 2025 Oct 1:jrheum.2025-0431. doi: 10.3899/jrheum.2025-0431.
    >> Share

  42. MAYO-JUANATEY A, Castaneda S, Calvo-Rio V, Garijo-Bufort M, et al
    Anifrolumab in Systemic Lupus Erythematosus With Severe Hematological Manifestations: A Spanish Multicenter Study.
    J Rheumatol. 2025 Oct 1:jrheum.2025-0658. doi: 10.3899/jrheum.2025-0658.
    >> Share

  43. RUBINSTEIN TB, Touma Z, Blanco I, Knight AM, et al
    Improving Mental Health Care for People With Systemic Lupus Erythematosus: Time to Take Action.
    J Rheumatol. 2025 Oct 1:jrheum.2025-0922. doi: 10.3899/jrheum.2025-0922.
    >> Share

    September 2025
  44. SINGH JA, Beasley M
    Patient Resilience is associated with Better Patient-Reported Physical and Mental/Emotional Quality of Life in Systemic Lupus Erythematosus.
    J Rheumatol. 2025 Sep 15:jrheum.2025-0396. doi: 10.3899/jrheum.2025-0396.
    >> Share

  45. YAU E, Chim T, Lim M, Inman RD, et al
    Anti-Integrin alphavbeta6 Autoantibodies as a Biomarker for Ulcerative Colitis in Patients With Axial Spondyloarthritis.
    J Rheumatol. 2025 Sep 15:jrheum.2024-1296. doi: 10.3899/jrheum.2024-1296.
    >> Share

  46. YE C, Nikolic RPA, Choi M, Fifi-Mah AV, et al
    Canadian Rheumatology Association/Canadian Research Group of Rheumatology in Immuno-Oncology Living Guidelines for Baseline Immunosuppression in Individuals With Preexisting Rheumatic Diseases Initiating Immune Checkpoint Inhibitors. Part 2: Preexisti
    J Rheumatol. 2025 Sep 15:jrheum.2025-0482. doi: 10.3899/jrheum.2025-0482.
    >> Share

  47. CONSOLARO A, Ruperto N, Lovell DJ, Synoverska O, et al
    Clinically Inactive Disease and Remission in Patients With Juvenile Idiopathic Arthritis Receiving Tofacitinib: Post Hoc Analysis of a Phase III Trial.
    J Rheumatol. 2025;52:919-926.
    >> Share

  48. JUNEK ML, Chanchlani R, Rodriguez AR, Khalidi N, et al
    Assessment of giant cell arteritis-associated visual outcomes at a tertiary hospital in Ontario, Canada.
    J Rheumatol. 2025 Sep 1:jrheum.2025-0459. doi: 10.3899/jrheum.2025-0459.
    >> Share

  49. ZAFFINO I, Boulard L, Law J, Danguecan A, et al
    Individual and Socio-ecological Resilience in Childhood-Onset Systemic Lupus Erythematosus: Associations with Patient Characteristics and Psychosocial Patient-Reported Outcomes.
    J Rheumatol. 2025 Sep 1:jrheum.2025-0375. doi: 10.3899/jrheum.2025-0375.
    >> Share

  50. LIN CH, Lin YP
    Classic Magnetic Resonance Imaging Features Unmask Progressive Multifocal Leukoencephalopathy in Rituximab-Treated Neuropsychiatric Systemic Lupus Erythematosus.
    J Rheumatol. 2025 Sep 1:jrheum.2025-0410. doi: 10.3899/jrheum.2025-0410.
    >> Share

  51. HORN KW, Breneman A, Djavid AR, Boneparth AD, et al
    A Rare and Severe Cutaneous Presentation of Systemic Lupus Erythematosus.
    J Rheumatol. 2025 Sep 1:jrheum.2025-0367. doi: 10.3899/jrheum.2025-0367.
    >> Share

    August 2025
  52. PEDERSEN MJ, Host C, Hansen SN, Klotsche J, et al
    School Absence Among Children With Juvenile Idiopathic Arthritis: A National Matched Comparison Study.
    J Rheumatol. 2025;52:801-809.
    >> Share

  53. ZIEMBA YC, Elkin EP, Kazemian E, Wilson BM, et al
    COVID-19 vaccine booster uptake and effectiveness among persons with systemic autoimmune and rheumatic diseases.
    J Rheumatol. 2025 Aug 1:jrheum.2025-0535. doi: 10.3899/jrheum.2025-0535.
    >> Share

    July 2025
  54. EL TAL T, Steiman A, Knight A, Hiraki LT, et al
    A Pediatric-Adult Provider Dyad Care Model Improves Transition From Pediatric to Adult Healthcare For Youth with Childhood-onset Systemic Lupus Erythematosus.
    J Rheumatol. 2025 Jul 25:jrheum.2025-0046. doi: 10.3899/jrheum.2025-0046.
    >> Share

  55. BRUNI C, Elhai M, Distler O
    Personalizing Management of Systemic Sclerosis-Associated Interstitial Lung Disease: Are Autoantibodies the Key for Risk Stratification?
    J Rheumatol. 2025 Jul 15:jrheum.2025-0692. doi: 10.3899/jrheum.2025-0692.
    >> Share

  56. PATEL H, DeMasters D, Tofferi J
    Antinuclear Antibody Multiplex Utilization Across a Large Federal Hospital System: An Investigation of Ordering Practices and Rheumatologic Outcomes.
    J Rheumatol. 2025;52:721-727.
    >> Share

  57. KHAROUF F, Mehta P, Alhadri A, Li Q, et al
    Comparative Analysis of Damage Accrual in Lupus Nephritis Stratified by Biological Sex.
    J Rheumatol. 2025 Jul 1:jrheum.2025-0302. doi: 10.3899/jrheum.2025-0302.
    >> Share

  58. KHAROUF F, Mehta P, Li Q, Gladman DD, et al
    Comparison of Lupus Nephritis Onset Before and After Age 50: Impact on Presentation and Outcomes in an Inception Cohort.
    J Rheumatol. 2025 Jul 1:jrheum.2024-1278. doi: 10.3899/jrheum.2024-1278.
    >> Share

  59. TEAW S, Shojaee A, Carnaru M, Hinchcliff M, et al
    The Risk and Time Course for Autoimmune Rheumatic Disease Development in Patients With Raynaud Phenomenon.
    J Rheumatol. 2025 Jul 1:jrheum.2024-0954. doi: 10.3899/jrheum.2024-0954.
    >> Share

  60. COHEN-HAGAI K, Saban M, Benchetrit S, Bar-Ziv D, et al
    Prevalence, Risk Factors, and Outcomes of Chronic Kidney Disease in Systemic Lupus Erythematosus Patients with and without Lupus Nephritis.
    J Rheumatol. 2025 Jul 1:jrheum.2024-1087. doi: 10.3899/jrheum.2024-1087.
    >> Share

  61. JUNEK ML, Okaj I, Patel S, Hu A, et al
    Multivariable models to predict a diagnosis of Giant Cell Arteritis: systematic review and meta-analysis.
    J Rheumatol. 2025 Jul 1:jrheum.2022-1204. doi: 10.3899/jrheum.2022-1204.
    >> Share

  62. SMITH JD, Pan B, Keeling S
    Identifying the State of Mental Health Care in Canadian Adults with Systemic Lupus Erythematosus.
    J Rheumatol. 2025 Jul 1:jrheum.2025-0089. doi: 10.3899/jrheum.2025-0089.
    >> Share

    May 2025
  63. GUNGORER V, Celik IK, Artac H, Celikel Acar B, et al
    OTULIN-Related Autoinflammatory Syndrome With a Novel Mutation Treated With Tumor Necrosis Factor Inhibitor Therapy: A Rare Case Report.
    J Rheumatol. 2025 May 15:jrheum.2024-1141. doi: 10.3899/jrheum.2024-1141.
    >> Share

  64. PIRES DA ROSA G, Granja BV, Azevedo F, Magina S, et al
    Pyoderma Gangrenosum-Associated Autoinflammatory Syndrome With Skin Abscesses: Successful Treatment With Anti-Interleukin 1 Therapy.
    J Rheumatol. 2025 May 15:jrheum.2025-0036. doi: 10.3899/jrheum.2025-0036.
    >> Share

  65. RODRIGUEZ-REYNA TS
    The Nuances of Shared Autoimmunity and the Singularity of Mixed Connective Tissue Disease.
    J Rheumatol. 2025 May 15:jrheum.2025-0463. doi: 10.3899/jrheum.2025-0463.
    >> Share

  66. JIANG Z, Barra L
    Does Prior Authorization for Tocilizumab Lead to Unacceptable Treatment Delays in Giant Cell Arteritis?
    J Rheumatol. 2025 May 15:jrheum.2025-0423. doi: 10.3899/jrheum.2025-0423.
    >> Share

  67. PLANTINGA LC, Roberts ET, Hoge C, Pearce BD, et al
    Indicators of Functional Disability by Receipt of Disability Benefits Among Individuals With Systemic Lupus Erythematosus.
    J Rheumatol. 2025;52:479-488.
    >> Share

  68. PATTERSON SL, Ruvalcaba D, Issa A, Rai K, et al
    Experiences with Complementary and Integrative Health Among People with Rheumatoid Arthritis and Systemic Lupus Erythematosus: A Qualitative Study.
    J Rheumatol. 2025 May 1:jrheum.2024-1218. doi: 10.3899/jrheum.2024-1218.
    >> Share

  69. KIM H
    Interferon Response Gene Score in Juvenile Dermatomyositis.
    J Rheumatol. 2025 May 1:jrheum.2025-0395. doi: 10.3899/jrheum.2025-0395.
    >> Share

    March 2025
  70. FETERMAN JIMENEZ D, Thomason JL, Liew JW, Ferguson S, et al
    Delays in Tocilizumab Therapy for Patients With Giant Cell Arteritis in the United States.
    J Rheumatol. 2025 Mar 15:jrheum.2024-0988. doi: 10.3899/jrheum.2024-0988.
    >> Share

  71. ICHIKAWA T, Kishida D, Shimojima Y, Yajima N, et al
    Trust in Health Information Sources Among Patients with Systemic Lupus Erythematosus in the Social Networking Era: The TRUMP(2)-SLE Study.
    J Rheumatol. 2025 Mar 15:jrheum.2024-1088. doi: 10.3899/jrheum.2024-1088.
    >> Share

  72. MACMAHON J, Massumi M, Duong TT, Garrett RH, et al
    Interferon Response Gene Score in Juvenile Dermatomyositis Correlates Strongly with Disease Activity.
    J Rheumatol. 2025 Mar 15:jrheum.2024-0806. doi: 10.3899/jrheum.2024-0806.
    >> Share

  73. GENER KR, Simakova E, Handal M
    Concurrent IgG4-Related Disease and Giant Cell Arteritis: A Rare Case Study.
    J Rheumatol. 2025 Mar 1:jrheum.2024-0861. doi: 10.3899/jrheum.2024-0861.
    >> Share

  74. AGUILA T, Madan R, Palmer MB, Derk CT, et al
    Zebra Bodies in Kidney Biopsy: Drug-Induced Phospholipidosis in a Patient With Systemic Lupus Erythematosus.
    J Rheumatol. 2025 Mar 1:jrheum.2024-1312. doi: 10.3899/jrheum.2024-1312.
    >> Share

    February 2025
  75. HIGHLAND KB, Chakravarty R, Georgi S, Han M, et al
    Patient Perspectives and Clinical Insights Into the Diagnostic Journey From Connective Tissue Disease to Pulmonary Arterial Hypertension.
    J Rheumatol. 2025 Feb 20:jrheum.2024-0613. doi: 10.3899/jrheum.2024-0613.
    >> Share

  76. AFLAKI M, Bargman JM
    Urine Protein Tests in Systematic Lupus Erythematosus: What Do They Mean?
    J Rheumatol. 2025 Feb 15:jrheum.2024-0910. doi: 10.3899/jrheum.2024-0910.
    >> Share

  77. STOUSTRUP P, Kellenberger CJ, Host C, Kuseler A, et al
    Effects of Biologics on Temporomandibular Joint Inflammation in Juvenile Idiopathic Arthritis.
    J Rheumatol. 2025;52:173-180.
    >> Share

  78. MUMTAZ S, Koster MJ, Warrington KJ
    Novel Photon-Counting Computed Tomography for the Evaluation of Large-Vessel Giant Cell Arteritis.
    J Rheumatol. 2025 Feb 1:jrheum.2024-1156. doi: 10.3899/jrheum.2024-1156.
    >> Share

  79. NISHAT F, Golding M, Merrill K, Protudjer JLP, et al
    Lived Education Experience of Young Adults with Childhood- and Adult-onset Systemic Lupus Erythematosus: A Multi-Centre Canadian Qualitative Study.
    J Rheumatol. 2025 Feb 1:jrheum.2024-0695. doi: 10.3899/jrheum.2024-0695.
    >> Share

  80. ABEL G, Ansari MQ, Snyder MR, Tebo AE, et al
    Historical Perspective on Antinuclear Antibody Testing.
    J Rheumatol. 2025 Feb 1:jrheum.2023-1121. doi: 10.3899/jrheum.2023-1121.
    >> Share

    December 2024
  81. GONZALEZ-GAY MA, Castaneda S, Ferraz-Amaro I
    Managing Giant Cell Arteritis With Tocilizumab: Relapses and Adverse Events.
    J Rheumatol. 2024 Dec 15:jrheum.2024-1204. doi: 10.3899/jrheum.2024-1204.
    >> Share

  82. HASLAK F, Kilic H, Sahin S, Hotaman B, et al
    Children With Type I Interferonopathy: Commonalities and Diversities in a Large Patient Cohort.
    J Rheumatol. 2024;51:1208-1217.
    >> Share

  83. MAILLE M, Tounkara BS, Vagner D, Bagny K, et al
    Epidemiology of isolated Cutaneous Lupus Erythematosus in the multiethnic population of Reunion Island (France): a retrospective multicentric study.
    J Rheumatol. 2024 Dec 1:jrheum.2024-0661. doi: 10.3899/jrheum.2024-0661.
    >> Share

    November 2024
  84. NAGASE FN, Fukui S, Takizawa N, Yamaguchi T, et al
    Tocilizumab for Giant Cell Arteritis: Clinical Outcomes Following Relapses and Tocilizumab Discontinuation Due to Adverse Events.
    J Rheumatol. 2024 Nov 15:jrheum.2024-0612. doi: 10.3899/jrheum.2024-0612.
    >> Share

  85. PARIMI VP, Ravindran V
    Cardiovascular Health and Adverse Pregnancy Outcomes in Autoimmune Rheumatic Diseases.
    J Rheumatol. 2024 Nov 15:jrheum.2024-0828. doi: 10.3899/jrheum.2024-0828.
    >> Share

  86. RANDELL RL, Reeve BB, Weitzman ER, von Scheven E, et al
    Pain Interference in Juvenile Idiopathic Arthritis.
    J Rheumatol. 2024;51:1119-1124.
    >> Share

  87. IMAI Y, Ota Y, Matsumoto K, Akiyama M, et al
    Performance of the 2022 ACR/EULAR Classification Criteria in Comparison With the European Medicines Agency Algorithm in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
    J Rheumatol. 2024;51:1102-1110.
    >> Share

  88. BRUNNER HI, Pacheco-Tena C, Louw I, Vega-Cornejo G, et al
    Intravenous Golimumab in Children With Polyarticular-Course Juvenile Idiopathic Arthritis: Long-Term Extension of an Open-Label Phase III Study.
    J Rheumatol. 2024;51:1125-1134.
    >> Share

  89. LIEBER SB, Young SR, Shea Y, Gottesman SP, et al
    The Lived Experiences of Older Adults with Systemic Lupus Erythematosus: Patient Perspectives.
    J Rheumatol. 2024 Nov 1:jrheum.2024-0478. doi: 10.3899/jrheum.2024-0478.
    >> Share

  90. ARDALAN K, Rider LG
    Ringing in the Patient Voice: Measuring Patients' Lived Experience of Dermatomyositis Symptoms.
    J Rheumatol. 2024 Nov 1:jrheum.2024-0951. doi: 10.3899/jrheum.2024-0951.
    >> Share

  91. JIANG Y, Duarte-Garcia A, Putman M, Gazeley D, et al
    Incidence of Pneumocystis jirovecii Pneumonia and Prophylaxis-Associated Adverse Events Among Patients with Systemic Lupus Erythematosus.
    J Rheumatol. 2024 Nov 1:jrheum.2023-1038. doi: 10.3899/jrheum.2023-1038.
    >> Share

    October 2024
  92. LIU X, Zhang J, Xu H, Kuang W, et al
    Epidemiological characteristics of patients with juvenile dermatomyositis in China: a multicenter study.
    J Rheumatol. 2024 Oct 15:jrheum.2024-0003. doi: 10.3899/jrheum.2024-0003.
    >> Share

  93. ZAREK J, Lee J, Harakati D, Spitzer K, et al
    Vitamin K Antagonists for Pregnant Women With Antiphospholipid Antibodies: A Scoping Review.
    J Rheumatol. 2024;51:964-972.
    >> Share

  94. OCAMPO-TORRES MC, Hernandez-Molina G, Criales-Vera S, Sanchez-Guerrero J, et al
    Coronary Artery Calcification Progression in Patients With Systemic Lupus Erythematosus.
    J Rheumatol. 2024;51:991-996.
    >> Share

  95. NIETO RE, Alarcon GS, Arnaud L, Pons-Estel GJ, et al
    Finding the Role of Anifrolumab in the New Paradigm of Systemic Lupus Erythematosus Treatment.
    J Rheumatol. 2024 Oct 1:jrheum.2024-0900. doi: 10.3899/jrheum.2024-0900.
    >> Share

    September 2024
  96. VYZHGA Y, Doria AS, Feldman BM, Tse SM, et al
    Mining for Gems: Early Detection of Calcinosis in Juvenile Dermatomyositis Using Low-Dose Computed Tomography.
    J Rheumatol. 2024 Sep 15:jrheum.2024-0594. doi: 10.3899/jrheum.2024-0594.
    >> Share

  97. KUWANA M, Wakasugi N, Hashida T, Uno S, et al
    Update on Tacrolimus in Patients With Interstitial Pneumonia Associated With Polymyositis or Dermatomyositis: 3-Year Postmarketing Surveillance Follow-Up in Japan.
    J Rheumatol. 2024 Sep 15:jrheum.2024-0379. doi: 10.3899/jrheum.2024-0379.
    >> Share

  98. AN J, Marwaha A, Laxer RM
    Autoinflammatory Diseases: A Review.
    J Rheumatol. 2024;51:848-861.
    >> Share

    August 2024
  99. AIRES BP, Wobma H, Samad A, Chandler MT, et al
    Severe Features of Systemic Juvenile Idiopathic Arthritis in Patients With Congenital Heart Disease.
    J Rheumatol. 2024;51:811-817.
    >> Share

  100. KARABUKAYEVA A, Hearld LR, Choi S, Singh JA, et al
    Patient Perspectives on a Decision Aid for Systemic Lupus Erythematosus: Insights and Future Considerations.
    J Rheumatol. 2024;51:798-803.
    >> Share

  101. PEDERSEN MJ, Host C, Hansen SN, Klotsche J, et al
    School Well-Being and Academic Performance of Children With Juvenile Idiopathic Arthritis: A National Register-Based Study.
    J Rheumatol. 2024;51:804-810.
    >> Share

  102. GOLDER V, Kandane-Rathnayake R, Louthrenoo W, Chen YH, et al
    Comparison of Attainment and Protective Effects of Lupus Low Disease Activity State in Patients With Newly Diagnosed Versus Established Systemic Lupus Erythematosus.
    J Rheumatol. 2024;51:790-797.
    >> Share

  103. OKITA Y, Okamoto M, Fujimoto J, Kumanogoh A, et al
    Pneumocephalus and Cerebral Abscess in Granulomatosis With Polyangiitis.
    J Rheumatol. 2024;51:832.
    >> Share

  104. YAMADA H, Sugiyama T, Ito Y, Toriihara A, et al
    Detection of Pancreatitis and Protein-Losing Gastroenteropathy Associated With Systemic Lupus Erythematosus by Protein Leakage Scintigraphy.
    J Rheumatol. 2024 Aug 1:jrheum.2024-0468. doi: 10.3899/jrheum.2024-0468.
    >> Share

  105. CHRISTOPHER-STINE L, Ciesluk A, Chinoy H, Goyal NA, et al
    The Dermatomyositis Disease Symptom Questionnaire (DM-DSQ): A Measure to Assess the Patient Experience of Dermatomyositis Symptoms.
    J Rheumatol. 2024 Aug 1:jrheum.2023-1137. doi: 10.3899/jrheum.2023-1137.
    >> Share

  106. GARG S, Plantinga LC
    A Bitter Pill to Swallow: The Challenge of Medication Nonadherence in Systemic Lupus Erythematosus.
    J Rheumatol. 2024 Aug 1:jrheum.2024-0654. doi: 10.3899/jrheum.2024-0654.
    >> Share

    July 2024
  107. BOWDISH DME, Chandran V, Hitchon CA, Kaplan GG, et al
    When Should I Get My Next COVID-19 Vaccine? Data From the Surveillance of Responses to COVID-19 Vaccines in Systemic Immune-Mediated Inflammatory Diseases (SUCCEED) Study.
    J Rheumatol. 2024;51:721-727.
    >> Share

  108. BAGGETT KH, Brandon TG, Xiao R, Weiss PF, et al
    Association of Infant Breastfeeding and Juvenile Spondyloarthritis: A Case-Control Study.
    J Rheumatol. 2024;51:708-714.
    >> Share

  109. TANI C, Cardelli C, Zen M, Moroni L, et al
    Anifrolumab In Refractory Systemic Lupus Erythematosus: A Real-Life, Multicenter Study.
    J Rheumatol. 2024 Jul 1:jrheum.2024-0053. doi: 10.3899/jrheum.2024-0053.
    >> Share

  110. TELES MS, Brundage J, Chiang TP, Alejo JL, et al
    Prevalence and Risk Factors of Post-Acute Sequela of COVID-19 in Adults with Systemic Autoimmune Rheumatic Diseases.
    J Rheumatol. 2024 Jul 1:jrheum.2023-1212. doi: 10.3899/jrheum.2023-1212.
    >> Share

    June 2024
  111. UGARTE-GIL MF, Alarcon GS
    Low Disease Activity Early in the Course of Systemic Lupus Erythematosus.
    J Rheumatol. 2024 Jun 15:jrheum.2024-0502. doi: 10.3899/jrheum.2024-0502.
    >> Share

  112. DHITAL R, Baer RJ, Bandoli G, Chambers C, et al
    Cardiovascular Events During Pregnancy: Implications for Adverse Pregnancy Outcomes in Individuals With Autoimmune and Rheumatic Diseases.
    J Rheumatol. 2024 Jun 15:jrheum.2024-0306. doi: 10.3899/jrheum.2024-0306.
    >> Share

  113. KOBAYASHI H, Yoshida Y, Kida T, Yajima N, et al
    Seasonal Effects on Relapse of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A Retrospective Multicenter Cohort Study in Japan (J-CANVAS).
    J Rheumatol. 2024;51:646-648.
    >> Share

  114. KWOK TSH, Zhou AL, Nguyen EL, Kwan A, et al
    Preliminary Development of a Novel Tool to Document Vessel Wall Involvement in Patients With Large-Vessel Vasculitis.
    J Rheumatol. 2024;51:637-639.
    >> Share

  115. MISZTAL MC, Gold N, Cao J, Diaz T, et al
    Genetics of Neonatal Lupus Erythematosus Risk and Specific Manifestations.
    J Rheumatol. 2024 Jun 1:jrheum.2023-1036. doi: 10.3899/jrheum.2023-1036.
    >> Share

  116. SUN K, Molokwu NJ, Hanlen-Rosado E, Corneli AL, et al
    Implementation of a clinician-led medication adherence intervention among patients with systemic lupus erythematosus.
    J Rheumatol. 2024 Jun 1:jrheum.2024-0071. doi: 10.3899/jrheum.2024-0071.
    >> Share

    May 2024
  117. KANIECKI T, Moyers B, Lubinus M, Hu YP, et al
    Patient Perspectives of the Manifestations and Treatment of Anti-MDA5 Antibody-Positive Dermatomyositis: An Observational Survey.
    J Rheumatol. 2024 May 15:jrheum.2024-0108. doi: 10.3899/jrheum.2024-0108.
    >> Share

  118. AKPOIGBE O, Anim-Koranteng C, Tasmin R, Sammut A, et al
    A Rare Case of Anti-Mi-2 Antibody-Positive Dermatomyositis Associated With Gastrointestinal Stromal Tumor.
    J Rheumatol. 2024 May 15:jrheum.2024-0114. doi: 10.3899/jrheum.2024-0114.
    >> Share

  119. AVASARALA J, Das S, Keshavamurthy S
    Point-of-Care Ultrasound With Artificial Intelligence-Driven Diagnostics in Giant Cell Arteritis: Blindness Prevention on a Global Scale.
    J Rheumatol. 2024 May 15:jrheum.2024-0217. doi: 10.3899/jrheum.2024-0217.
    >> Share

  120. BRIDGES JM, Li J, Mannion ML, Clowse MEB, et al
    Contraception Care Patterns for Adult Females With Juvenile Idiopathic Arthritis on Teratogens in the Rheumatology Informatics System for Effectiveness (RISE) Registry.
    J Rheumatol. 2024;51:542-545.
    >> Share

    April 2024
  121. SEMALULU T, Berard R, Beattie K, Basodan D, et al
    Clinical Characteristics of Adolescents With Juvenile Idiopathic Arthritis Transitioning to Adult Rheumatology Care in Canada: Results From the CAPRI Registry.
    J Rheumatol. 2024;51:403-407.
    >> Share

  122. OWN M, Bloostein A, Spiera R, Berman JR, et al
    Systemic Sclerosis in Individuals With Exposure to World Trade Center Ground Zero Rescue and Recovery Efforts: A Case Series.
    J Rheumatol. 2024;51:390-395.
    >> Share

  123. CONTRERAS MARTIN GN
    Lupus Nephritis Treatment Strategies.
    J Rheumatol. 2024 Apr 1:jrheum.2024-0172. doi: 10.3899/jrheum.2024-0172.
    >> Share

  124. JUNEK M, Barra L, Kopp A, Felfeli T, et al
    Phase Specific Health Care Costs Associated with Giant Cell Arteritis in Ontario, Canada.
    J Rheumatol. 2024 Apr 1:jrheum.2023-1245. doi: 10.3899/jrheum.2023-1245.
    >> Share

  125. ROBERTS JE, Faino A, Bryan MA, Cogen JD, et al
    Hospitalization and Mortality due to Infection among United States Children and Adolescents with Systemic Lupus Erythematosus.
    J Rheumatol. 2024 Apr 1:jrheum.2023-1219. doi: 10.3899/jrheum.2023-1219.
    >> Share

    March 2024
  126. YAMAMOTO H, Taniguchi Y
    Cranial Giant Cell Arteritis and Subdural Hematoma.
    J Rheumatol. 2024 Mar 15:jrheum.2024-0008. doi: 10.3899/jrheum.2024-0008.
    >> Share

  127. YENNEMADI AS, Jordan N, Diong S, Keane J, et al
    The Link Between Dysregulated Immunometabolism and Vascular Damage: Implications for the Development of Atherosclerosis in Systemic Lupus Erythematosus and Other Rheumatic Diseases.
    J Rheumatol. 2024;51:234-241.
    >> Share

  128. FALASINNU T, Nguyen T, Jiang TE, Tamang S, et al
    The Problem of Pain in Rheumatology: Variations in Case Definitions Derived From Chronic Pain Phenotyping Algorithms Using Electronic Health Records.
    J Rheumatol. 2024;51:297-304.
    >> Share

  129. YASUDA N, Yamane T
    Leg Gangrene in Granulomatosis With Polyangiitis.
    J Rheumatol. 2024;51:316-317.
    >> Share

  130. PATEL NJ, Wang X, Lin M, Kowalski EN, et al
    Factors Associated with an Electronic Health Record-Based Definition of Post-Acute Sequelae of COVID-19 in Patients with Systemic Autoimmune Rheumatic Disease.
    J Rheumatol. 2024 Mar 1:jrheum.2023-1092. doi: 10.3899/jrheum.2023-1092.
    >> Share

  131. DAWOUD SA, Ahmad NU, Shriver EM, Chung SM, et al
    Orbital and Optic Nerve Sheath Involvement and Pupil-Involving Cranial Nerve 3 Palsy in Giant Cell Arteritis.
    J Rheumatol. 2024 Mar 1:jrheum.2023-1195. doi: 10.3899/jrheum.2023-1195.
    >> Share

  132. MORAND EF, Jones SA
    Flare in Systemic Lupus Erythematosus: Lost in Translation?
    J Rheumatol. 2024 Mar 1:jrheum.2024-0122. doi: 10.3899/jrheum.2024-0122.
    >> Share

    February 2024
  133. TAKEUCHI T, Wakasugi N, Hashida T, Uno S, et al
    Long-term safety and effectiveness of tacrolimus in patients with lupus nephritis in Japan: 10-year analysis of the real-world TRUST study.
    J Rheumatol. 2024 Feb 15:jrheum.2023-0210. doi: 10.3899/jrheum.2023-0210.
    >> Share

  134. WALSH M, Strouse J, Bettendorf B
    Paget Disease as a Rare Mimicker of Giant Cell Arteritis.
    J Rheumatol. 2024 Feb 15:jrheum.2023-1160. doi: 10.3899/jrheum.2023-1160.
    >> Share

  135. SAGY I, Schwarzfuchs O, Zeller L, Ling E, et al
    Short- and Long-Term Mortality of Hospitalized Patients with Autoimmune Rheumatic Diseases and Serious Infections: A National Cohort Study.
    J Rheumatol. 2024 Feb 1:jrheum.2023-1063. doi: 10.3899/jrheum.2023-1063.
    >> Share

  136. ALPERS CE
    Antiphospholipid Antibodies (aPL) and Thrombotic Microangiopathy for the Diagnosis of aPL Nephropathy: You Can't Have One Without the Other.
    J Rheumatol. 2024;51:109-111.
    >> Share

  137. PEDERSEN MJ, Host C, Hansen SN, Deleuran BW, et al
    Psychiatric Morbidity Is Common Among Children With Juvenile Idiopathic Arthritis: A National Matched Cohort Study.
    J Rheumatol. 2024;51:181-188.
    >> Share

    December 2023
  138. ROGERS JL, Clowse MEB, McKenna K, Starling S, et al
    Patient and physician perspectives of systemic lupus erythematosus flare: A qualitative study.
    J Rheumatol. 2023 Dec 15:jrheum.2023-0721. doi: 10.3899/jrheum.2023-0721.
    >> Share

  139. SKYDEL JJ, Ramachandran R, Suttiratana S, Ross JS, et al
    Geographic and Demographic Representation in Industry-Sponsored, US-Based Clinical Trials of Systemic Lupus Erythematosus Therapies.
    J Rheumatol. 2023 Dec 15:jrheum.2023-0920. doi: 10.3899/jrheum.2023-0920.
    >> Share

    November 2023
  140. TOUMA Z, Parodis I, Strand V
    More Evidence on the Validity of the Measurement Properties of PROMIS Computerized Adaptive Tests in Systemic Lupus Erythematosus.
    J Rheumatol. 2023 Nov 15:jrheum.2023-0947. doi: 10.3899/jrheum.2023-0947.
    >> Share

  141. RUBENSTEIN E, Maldini C, Vaglio A, Bello F, et al
    Cluster Analysis to Explore Clinical Subphenotypes of Eosinophilic Granulomatosis With Polyangiitis.
    J Rheumatol. 2023;50:1446-1453.
    >> Share

  142. ROZENBLYUM EV, Chan MO, Gakhal NK
    Chew on This: The Afterbite of Temporomandibular Joint Involvement in Adults With Juvenile Idiopathic Arthritis.
    J Rheumatol. 2023;50:1364-1366.
    >> Share

  143. RUPERTO N, Lovell DJ, Berman A, Anton J, et al
    Abatacept as Monotherapy and in Combination With Methotrexate in Patients With Juvenile Idiopathic Arthritis: Analysis of 2 Phase III Trials.
    J Rheumatol. 2023;50:1471-1480.
    >> Share

  144. DE SONNAVILLE WFC, Speksnijder CM, Zuithoff NPA, Heijstek MW, et al
    Clinically Established Temporomandibular Involvement in Adults With Juvenile Idiopathic Arthritis.
    J Rheumatol. 2023;50:1462-1470.
    >> Share

  145. OGURO N, Yajima N, Ishikawa Y, Sakurai N, et al
    Impact of Attending Rheumatologist's Big Five Personality Traits on Systemic Lupus Erythematosus Patients' Trust: The TRUMP2-SLE Project.
    J Rheumatol. 2023 Nov 1:jrheum.2023-0603. doi: 10.3899/jrheum.2023-0603.
    >> Share

    October 2023
  146. SUN YS, Huang DF, Chen WS, Liao HT, et al
    Risk factor and incidence of serious infections in systemic lupus erythematosus patients undergoing rituximab therapy.
    J Rheumatol. 2023 Oct 15:jrheum.2023-0623. doi: 10.3899/jrheum.2023-0623.
    >> Share

  147. PARREAU S, Dumonteil S, Gondran G, Bezanahary H, et al
    Frequency and Significance of Hepatic Involvement in New-Onset Giant Cell Arteritis: A Study of 514 Patients.
    J Rheumatol. 2023 Oct 15:jrheum.2023-0358. doi: 10.3899/jrheum.2023-0358.
    >> Share

  148. KAWANO Y, Wang X, Patel NJ, Qian G, et al
    Breakthrough COVID-19 after tixagevimab/cilgavimab among patients with systemic autoimmune rheumatic diseases.
    J Rheumatol. 2023 Oct 15:jrheum.2023-0742. doi: 10.3899/jrheum.2023-0742.
    >> Share

  149. NIETO-GONZALEZ JC, Garulo DC, Boteanu A, Trives-Folguera L, et al
    What to Expect When Systemic Treatment in Juvenile Idiopathic Arthritis Is Withdrawn?
    J Rheumatol. 2023;50:1326-1332.
    >> Share

  150. AGUIRRE A, DeQuattro K, Shiboski S, Katz P, et al
    Medication Cost Concerns and Disparities in Patient-Reported Outcomes Among a Multiethnic Cohort of Patients With Systemic Lupus Erythematosus.
    J Rheumatol. 2023;50:1302-1309.
    >> Share

  151. LIU S, Han L, Li M, Tian X, et al
    Sex Differences in Clinical Manifestations of Hospitalized Patients With Eosinophilic Granulomatosis With Polyangiitis: A Retrospective Cohort Study.
    J Rheumatol. 2023;50:1318-1325.
    >> Share

  152. QUINTANA R, Ramirez-Flores MF, Fuentes-Silva Y, Pelaez-Ballestas I, et al
    Diagnostic Delay in Autoimmune Rheumatic Diseases: A Global Health Problem.
    J Rheumatol. 2023 Oct 1:jrheum.2023-0847. doi: 10.3899/jrheum.2023-0847.
    >> Share

    September 2023
  153. PESKIN M, Mostowy M, Velez J, Perron M, et al
    Clinical improvement in early onset interstitial lung disease using rituximab in children with anti-MDA5 positive juvenile dermatomyositis.
    J Rheumatol. 2023 Sep 15:jrheum.2023-0544. doi: 10.3899/jrheum.2023-0544.
    >> Share

  154. SASAI T, Nakashima R, Tsuji H, Nakajima T, et al
    Long term prognosis of anti-melanoma differentiation-associated gene 5-positive dermatomyositis with interstitial lung disease.
    J Rheumatol. 2023 Sep 15:jrheum.2023-0371. doi: 10.3899/jrheum.2023-0371.
    >> Share

  155. YOSHIDA Y, Nakamoto N, Oka N, Kidoguchi G, et al
    Seasonal Influence on Development of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A Retrospective Cohort Study Conducted at Multiple Institutions in Japan (J-CANVAS).
    J Rheumatol. 2023;50:1152-1158.
    >> Share

  156. WEISS PF, Brandon TG, Lambert RG, Biko DM, et al
    Consensus-Driven Definition for Unequivocal Sacroiliitis on Radiographs in Juvenile Spondyloarthritis.
    J Rheumatol. 2023;50:1173-1177.
    >> Share

  157. MOISEEV S, Bulanov N, Crnogorac M, Direskeneli H, et al
    Traditional and Disease-Specific Risk Factors for Cardiovascular Events in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A Multinational Retrospective Study.
    J Rheumatol. 2023;50:1145-1151.
    >> Share

  158. FERUCCI ED
    Improving Outcomes in Systemic Lupus Erythematosus: The Importance of Access to Medications.
    J Rheumatol. 2023 Sep 1:jrheum.2023-0772. doi: 10.3899/jrheum.2023-0772.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016